Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Dec 20 2025
Feb 12 2026
Oct 7 2025
Nov 10 2025
Dec 1 2025